escent iodoargentates with bisimidazole derivatives as countercations †

Rongyan Wang,Xiao Zhang,Jie-hui Yu,Jianping Xua
2018-01-01
Abstract:Rong-Yan Wang, Xiao Zhang, *b Jie-Hui Yu *a and Ji-Qing Xu In this article, three bisimidazole derivatives (1,4-bis(2-ethylimidazol-1-yl)butane, L1; 4,40-di(1H-imidazol-1yl)-1,10-biphenyl, L20; and 1,3-bis(2-ethylimidazol-1-yl)propane, L3) were employed to solvothermally react with AgI in an acidic environment, creating three new 1-D chained iodoargentates [H(L1)][Ag5I6]$DMF (DMF 1⁄4 N,N0-dimethylformamide) 1, [L2][Ag3I5] (L2 1⁄4 4,40-di(1H-imidazol-1-ium)-1,10-biphenyl) 2, and [H2(L3)] [Ag2I4] 3. L2 2+ in 2 originated from the in situ N-alkylation of L20 with the CH3OH solvent. X-ray singlecrystal diffraction analysis reveals that (i) in 1, Ag and I aggregate to form a 1-D tube-like iodoargentate, which exhibits the same topology as the carbon tube; (ii) the chain structure of the iodoargentate in 2 is based on a kind of trinuclear Ag–I cluster, which can be viewed as a segment of the classical cubic M4I4 cluster; (iii) the chain structure of the iodoargentate in 3 is simple, which can be described as a linear arrangement of the AgI4 tetrahedra by sharing edges. The photoluminescence analysis reveals that at 77 K, (i) 1 and 2 emit strong yellow light with ms-grade photoluminescence lifetimes (5.460 ms for 1, 6.931 ms for 2); (ii) 3 possesses photochromic luminescence properties. Upon excitation at 254 nm, it emits blue-green light, whereas upon excitation at 365 nm, it emits yellow light.
What problem does this paper attempt to address?